The DOI matches its Crossref record; 194 of the 194 references it cites were found in a registry or an index.
Apolipoprotein E: Structure-Function Relationships
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“We identified Gly145Asp and Arg154Cys in the same J o u r n a l P r e -p r o o f region (amino acids ~ 148 to 168) [47]”
From APOE and vascular disease: Sequencing and genotyping in general population cohorts (2023) · cites this paper as [47]
In the citing paper
“Variants predicted by models to be deleterious or being located near or in the receptor binding region (amino acids ~ 148 to 168) [47] could be suspected to pose ε2-like qualities.”
From APOE and vascular disease: Sequencing and genotyping in general population cohorts (2023) · cites this paper as [47]
In the citing paper
“Additional support comes from the present data, where Gly145Asp and Arg154Cys are located in the receptor binding region (amino acids ≈148 to 168) 28 and display a phenotype similar to the ɛ2‐defining Arg176Cys residue with high apoE levels and seemingly low risk of dementia (no events).”
From APOE and dementia – resequencing and genotyping in 105,597 individuals (2020) · cites this paper as [28]
In the citing paper
“Val254Glu and Arg269Gly are located in the lipid‐binding carboxyl‐terminal domain (amino acids ≈243 to 317). 28 , 42”
From APOE and dementia – resequencing and genotyping in 105,597 individuals (2020) · cites this paper as [28]
In the citing paper
“However, the receptor-binding sites (AA136-150) for lipoprotein receptors such as the low-density lipoprotein receptor (LDLR), lipoprotein-related receptor 1 (LRP1), and heparan sulfate proteoglycans (HSPGs) are located in a region conserved between species (Fig. 1a) [11–14].”
From APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology (2025) · cites this paper as [12]
In the citing paper
“Notably, an HSPG and LDLR binding site in the APOE sequence is conserved in mice (blue boxed area, AA136-150), including arginine 136, which is replaced by serine in the Christchurch (Ch) variant [12, 39].”
From APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology (2025) · cites this paper as [12]
In the citing paper
“However, mAPOE and hAPOE have a conserved LDLR and HSPG binding motif between AA136 to 150 (human numbering) [11, 12, 39], which includes the R136S Christchurch variant.”
From APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology (2025) · cites this paper as [12]
In the citing paper
“The mature apoE protein consists of 299 amino acids and an 18amino acid signal peptide is removed post-translationally [17,28].”
From Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review (2016) · cites this paper as [28]
In the citing paper
“The APOE gene is located on chromosome 19 and consists of four exons [28].”
From Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review (2016) · cites this paper as [28]
In the citing paper
“Lipid-free apoE consists of two domains connected by a “hinge region”: the amino-terminal domain (amino acids 1 to 191) contains the receptor-binding function and the carboxyl-terminal domain (~amino acids 225 to 299) contains the lipid-binding function [28,33].”
From Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review (2016) · cites this paper as [28]
In the citing paper
“The low density lipoprotein (LDL) receptor binding region is situated in helix four between amino acids 136 and 150 [17,28].”
From Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review (2016) · cites this paper as [28]
In the citing paper
“ApoE2 exhibits a lower affinity to the LDL receptor compared to apoE3: ~1% of the binding activity of apoE3 and apoE4 [28,36].”
From Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review (2016) · cites this paper as [28]
In the citing paper
“Furthermore, apoE and apoB share the sequence with highest affinity for arterial proteoglycans, a key phenomenon for lipoprotein deposition in the arterial wall [28,63].”
From Plasma levels of apolipoprotein E, APOE genotype and risk of dementia and ischemic heart disease: A review (2016) · cites this paper as [28]
In the citing paper
“ApoE contains two independently folded functional domains; these are a 22-kDa N-terminal domain (residues 1–191) and a 10-kDa C-terminal domain (residues 216–299) linked by a hinge region (18, 19).”
From Role of the N- and C-Terminal Domains in Binding of Apolipoprotein E Isoforms to Heparan Sulfate and Dermatan Sulfate: A Surface Plasmon Resonance Study (2008) · cites this paper as [18]
Citations
Cites
The Metabolic Basis of Inherited Disease.
(1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-108-3-503_7 · Cited by 7,807
A Receptor-Mediated Pathway for Cholesterol Homeostasis
Brown, M. S., & Goldstein, J. L. (1986) · Science · doi:10.1126/science.3513311 · Cited by 5,703
Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1977 · Cited by 4,268
Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell Biology
Mahley, R. W. (1988) · Science · doi:10.1126/science.3283935 · Cited by 4,028
The Leucine Zipper: A Hypothetical Structure Common to a New Class of DNA Binding Proteins
Landschulz, W. H., Johnson, P. F., & McKnight, S. L. (1988) · Science · doi:10.1126/science.3289117 · Cited by 3,443
Prediction of protein conformation
Chou, P. Y., & Fasman, G. D. (1974) · Biochemistry · doi:10.1021/bi00699a002 · Cited by 3,309
The plasma lecithin:cholesterol acyltransferase reaction
Glomset, J. A. (1968) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)43114-1 · Cited by 2,396
Plump, A. S., Smith, J. D., Hayek, T., Aalto-Setälä, K., Walsh, A., Verstuyft, J. G., Rubin, E. M., & Breslow, J. L. (1992) · Cell · doi:10.1016/0092-8674(92)90362-g · Cited by 2,263
Spontaneous Hypercholesterolemia and Arterial Lesions in Mice Lacking Apolipoprotein E
Zhang, S. H., Reddick, R. L., Piedrahita, J. A., & Maeda, N. (1992) · Science · doi:10.1126/science.1411543 · Cited by 2,237
Apolipoprotein E polymorphism and atherosclerosis.
Davignon, J., Gregg, R. E., & Sing, C. F. (1988) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.8.1.1 · Cited by 1,981
Research works printed but not linked: 17
- Cassel, 1984, Atherosclerosis (Shannon, Irel.), 52, 203
- Hallman, 1991, Am. J. Hum. Genet., 49, 338
- Havel, 1989, 1, 1129
- Koizumi, 1985, Antherosclerosis (Shannon, Irel.), 58, 175
- Landis, 1987, Am. J. Physiol., 252, G805
- Lund-Katz, 1993, J. Biol. Chem.
- Mahley, 1983, Arch. Pathol. Lab. Med., 107, 393
- Mahley, 1989, 1, 1195
- Mahley, 1983, 4, 151
- Mahley, 1977, Am. J. Pathol., 87, 205
- Mahley, 1983, Biochim. Biophys. Acta., 737, 197, 10.1016/0304-4157(83)90001-1 · DOI
- Mahley, 1989, 1, 1195
- Phillips, 1986, 128, 387
- Srinivasan, 1972, Atherosclerosis (Shannon, Irel.), 16, 95
- Utermann, 1980, Am. J. Hum. Genet., 32, 339
- Weisgraber, 1983, 4, 103
- Yamamura, 1984, Atherosclerosis (Shannon, Irel.), 50, 159
Cited by
Sorted by citations
Items 501–600 of 828
Lipid-free apoA-I structure - Origins of model diversity
Oda, M. N. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.11.010 · Cited by 24
Eberlé, D., Kim, R. Y., Luk, F. S., de Mochel, N. S. R., Gaudreault, N., Olivas, V. R., Kumar, N., Posada, J. M., Birkeland, A. C., Rapp, J. H., et al. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.246389 · Cited by 21
James, M. L., Komisarow, J. M., Wang, H., & Laskowitz, D. T. (2020) · Neurotherapeutics · doi:10.1007/s13311-020-00858-x · Cited by 24
Faraji, P., Kühn, H., & Ahmadian, S. (2024) · Journal of Molecular Neuroscience · doi:10.1007/s12031-024-02224-4 · Cited by 25
Noh, J. Y., Patnaik, B. B., Tindwa, H. J., Seo, G. W., Kim, D. H., Patnaik, H. H., Jo, Y. H., Lee, Y. S., Lee, B. L., Kim, N. J., et al. (2013) · Gene · doi:10.1016/j.gene.2013.10.058 · Cited by 21
Obulesu, M., Somashekhar, R., & Venu, R. (2011) · International Journal of Neuroscience · doi:10.3109/00207454.2010.551432 · Cited by 20
Atageldiyeva, K. K., Nemr, R., Echtay, A. S., Racoubian, E., Sarray, S., & Almawi, W. Y. (2019) · Gene · doi:10.1016/j.gene.2019.144011 · Cited by 21
Zerbinatti, C., & Dyer, C. A. (1999) · Biology of Reproduction · doi:10.1095/biolreprod61.3.665 · Cited by 21
Frikke-Schmidt, R., Sing, C., Nordestgaard, B., & Tybj�rg-Hansen, A. (2004) · Human Genetics · doi:10.1007/s00439-004-1165-z · Cited by 21
Raffai, R., Maurice, R., Weisgraber, K., Innerarity, T., Wang, X., MacKenzie, R., Hirama, T., Watson, D., Rassart, E., & Milne, R. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)41109-5 · Cited by 21
Self-citationApoE genotypes are associated with age at natural menopause in Chinese females
Meng, F., Wang, Y., Liu, J., Zhao, J., Liu, R., & Zhou, J. (2011) · AGE · doi:10.1007/s11357-011-9287-4 · Cited by 20
Genetic polymorphism at the apolipoprotein E locus affects the outcome of chronic hepatitis B
Toniutto, P., Fattovich, G., Fabris, C., Minisini, R., Burlone, M. E., Pravadelli, C., Peraro, L., Falleti, E., Caldera, F., Bitetto, D., et al. (2009) · Journal of Medical Virology · doi:10.1002/jmv.21642 · Cited by 20
Thilakawardhana, S. B., Everett, D. M., Murdock, P. R., Dingwall, C., & Owen, J. S. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.08.004 · Cited by 21
Zhao, W., Zhang, Y., Cui, C., Li, Q., & Wang, J. (2008) · Protein Science · doi:10.1110/ps.073383708 · Cited by 20
Lipoproteins produced by ApoE–/– astrocytes infected with adenovirus expressing human ApoE
Peng, D., Song, C., Reardon, C. A., Liao, S., & Getz, G. S. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01950.x · Cited by 19
Clément‐Collin, V., Leroy, A., Monteilhet, C., & Aggerbeck, L. P. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00608.x · Cited by 20
Huber, G., März, W., Martin, J. R., Malherbe, P., Richards, J. G., Sueoka, N., Ohm, T., & Hoffmann, M. M. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00341-9 · Cited by 20
Apolipoprotein E4 as a Target for Developing New Therapeutics for Alzheimer's Disease
Refolo, L. M., & Fillit, H. M. (2004) · Journal of Molecular Neuroscience · doi:10.1385/jmn:23:3:151 · Cited by 20
A Thyroid Hormone Binding Motif Is Evolutionarily Conserved in Apolipoproteins
Benvenga, S. (1997) · Thyroid · doi:10.1089/thy.1997.7.605 · Cited by 20
Porcine Cerebroside Sulfate Activator (Saposin B) Secondary Structure: CD, FTIR, and NMR Studies
Waring, A. J., Chen, Y., Faull, K. F., Stevens, R. L., Sherman, M. A., & Fluharty, A. L. (1998) · Molecular Genetics and Metabolism · doi:10.1006/mgme.1997.2646 · Cited by 20
Current insights into apolipoprotein E and the immune response in Alzheimer's disease
Lin, P. B., & Holtzman, D. M. (2024) · Immunological Reviews · doi:10.1111/imr.13414 · Cited by 19
Lipponen, K., Liu, Y., Stege, P. W., Öörni, K., Kovanen, P. T., & Riekkola, M.-L. (2012) · Analytical Biochemistry · doi:10.1016/j.ab.2012.02.017 · Cited by 20
Goyal, M., Grover, S., Dhanjal, J. K., Goyal, S., Tyagi, C., Chacko, S., & Grover, A. (2013) · BioMed Research International · doi:10.1155/2013/620793 · Cited by 19
Effect of fenofibrate and atorvastatin on VLDL apoE metabolism in men with the metabolic syndrome
Ooi, E. M. M., Ng, T. W., Watts, G. F., Chan, D. C., & Barrett, P. H. R. (2012) · Journal of Lipid Research · doi:10.1194/jlr.p029223 · Cited by 19
Zhao, W., Du, F., Zhang, M., Sun, S., Yu, H., & Fan, D. (2011) · Experimental Biology and Medicine · doi:10.1258/ebm.2011.011169 · Cited by 19
Roses, A. D., Gilbert, J. R., Xu, P., Sullivan, P. M., Popko, B., Burkhart, D., Christian-Rothrock, T., Saunders, A. M., Maeda, N., & Schmechel, D. E. (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00030-x · Cited by 19
Endogenous heparin activity deficiency: the ‘Missing Link’ in atherogenesis?
Engelberg, H. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(01)00650-5 · Cited by 19
Riddell, D. R., & Owen, J. S. (1995) · Thrombosis Research · doi:10.1016/0049-3848(95)00205-7 · Cited by 19
Human apolipoprotein E glycosylation and sialylation: from structure to function
Moon, H.-J., Luo, Y., Chugh, D., & Zhao, L. (2024) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2024.1399965 · Cited by 18
Chen, H., Jiang, D., Li, Z., Wang, Y., Yang, X., Li, S., Li, S., Yang, W., & Li, G. (2021) · Life · doi:10.3390/life11060589 · Cited by 18
Martin, W., Sheynkman, G., Lightstone, F. C., Nussinov, R., & Cheng, F. (2021) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2021.09.001 · Cited by 20
Figueiredo, S., & Devezas, M. (2024) · Perioperative Care and Operating Room Management · doi:10.1016/j.pcorm.2024.100401 · Cited by 19
Rougeron, V., Woods, C. M., Tiedje, K. E., Bodeau‐Livinec, F., Migot‐Nabias, F., Deloron, P., Luty, A. J. F., Fowkes, F. J. I., & Day, K. P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076924 · Cited by 18
The apolipoprotein E polymorphism and cardiovascular diseases—an autopsy study
Kumar, N. T., Liestøl, K., Løberg, E. M., Reims, H. M., Brorson, S.-H., & Mæhlen, J. (2012) · Cardiovascular Pathology · doi:10.1016/j.carpath.2012.02.005 · Cited by 19
Apolipoprotein E modifies the CNS response to injury via a histamine-mediated pathway
Mace, B. E., Wang, H., Lynch, J., Moss, J. M., Sullivan, P. M., Colton, H. M., Morgan, K. T., Renauld, J., & Laskowitz, D. T. (2007) · Neurological Research · doi:10.1179/016164107x158974 · Cited by 18
Chen, Y., Lei, K., Liu, Y., Liu, J., Wei, K., Guo, J., & Su, Z. (2025) · Biomolecules · doi:10.3390/biom15070990 · Cited by 20
Bumber, J. R., Rački, V., Mežnarić, S., Pelčić, G., & Mršić‐Pelčić, J. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14176047 · Cited by 19
Genetic Factors That Could Affect Concussion Risk in Elite Rugby
Antrobus, M., Brazier, J., Stebbings, G. K., Day, S. H., Heffernan, S. M., Kilduff, L. P., Erskine, R. M., & Williams, A. G. (2021) · Sports · doi:10.3390/sports9020019 · Cited by 19
A complete backbone spectral assignment of lipid-free human apolipoprotein E (apoE)
Zhang, Y., Chen, J., & Wang, J. (2008) · Biomolecular NMR Assignments · doi:10.1007/s12104-008-9122-8 · Cited by 17
Duggan, A. E., & Callard, I. P. (2001) · Journal of Experimental Zoology · doi:10.1002/jez.1056 · Cited by 17
Ooi, E. M. M., Janus, E. D., Grant, S. J., Sinclair, L. M. T., & R.Barrett, P. H. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m004705 · Cited by 16
Comparative in vivo metabolism of apolipoproteins E2 and E4 in heterozygous apoE2/4 subjects
Ikewaki, K., Zech, L. A., Brewer, H. B., & Rader, D. J. (2002) · Journal of Laboratory and Clinical Medicine · doi:10.1067/mlc.2002.129066 · Cited by 17
Structure–function properties of the apoE-dependent COX-2 pathway in vascular smooth muscle cells
Ali, K., Lund‐Katz, S., Lawson, J. A., Phillips, M. C., & Rader, D. J. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.03.038 · Cited by 18
Apolipoprotein E gene polymorphism in psoriasis
Karpouzis, A., Caridha, R., Tripsianis, G., Michailidis, C., Martinis, G., & Veletza, S. V. (2009) · Archives of Dermatological Research · doi:10.1007/s00403-009-0968-0 · Cited by 17
Apolipoprotein E-Related Neurotoxicity as a Therapeutic Target for Alzheimer's Disease
Marques, M. A., & Crutcher, K. A. (2003) · Journal of Molecular Neuroscience · doi:10.1385/jmn:20:3:327 · Cited by 17
Defective Chylomicron Synthesis as a Cause of Delayed Particle Clearance in Diabetes?
Phillips, C. M., Madigan, C. D., Owens, D., Collins, P. B., & TOMKIN, G. H. (2002) · Journal of Diabetes Research · doi:10.1080/15604280214277 · Cited by 17
Raffaı̈, R. L., Weisgraber, K. H., MacKenzie, R., Rupp, B., Rassart, É., Hirama, T., Innerarity, T. L., & Milne, R. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.10.7109 · Cited by 17
Self-citationLazo, N. D., Maji, S. K., Fradinger, E. A., Bitan, G., & Teplow, D. B. (2005) · Wiley eBooks · doi:10.1002/9783527619344.ch17 · Cited by 18
Apolipoprotein E isoform dependently affects Tat-mediated HIV-1 LTR transactivation
Khan, N., Datta, G., Geiger, J. D., & Chen, X. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1129-1 · Cited by 16
Endogenous Human Proteins Interfering with Amyloid Formation
Gharibyan, A. L., Jayaweera, S. W., Lehmann, M., Anan, I., & Olofsson, A. (2022) · Biomolecules · doi:10.3390/biom12030446 · Cited by 17
Apolipoprotein E Gene Variants on the Risk of End Stage Renal Disease
Xue, C., Nie, W., Tang, D., Yi, L., & Mei, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083367 · Cited by 16
Newhouse, Y., Peters-Libeu, C., & Weisgraber, K. H. (2005) · Acta Crystallographica Section F Structural Biology and Crystallization Communications · doi:10.1107/s1744309105032410 · Cited by 15
Self-citationFluorescence study of domain structure and lipid interaction of human apolipoproteins E3 and E4
Mizuguchi, C., Hata, M., Dhanasekaran, P., Nickel, M., Okuhira, K., Phillips, M. C., Lund‐Katz, S., & Saito, H. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.09.019 · Cited by 16
Lipid metabolism in Alzheimer’s and Parkinson’s disease
Xu, Q., & Huang, Y. (2006) · Future Lipidology · doi:10.2217/17460875.1.4.441 · Cited by 16
Madigan, C., Ryan, M., Owens, D., Collins, P. B., & TOMKIN, G. H. (2005) · Irish Journal of Medical Science (1971 -) · doi:10.1007/bf03168513 · Cited by 16
Effects of Apolipoprotein E Genotype on Blood Cholesterol in Adolescent Girls
Fulton, J. E., Dai, S., Grunbaum, J. A., Boerwinkle, E., & Labarthe, D. R. (2009) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2009.04.009 · Cited by 16
Trakhanov, S. D., Parkin, S., Raffaı̈, R. L., Milne, R. W., Newhouse, Y. M., Weisgraber, K. H., & Rupp, B. (1999) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s090744499800938x · Cited by 16
Self-citationThe N-Terminus of Apolipoprotein A-V Adopts a Helix Bundle Molecular Architecture
Mauldin, K., Beckstead, J. A., Lee, D., Weers, P. M. M., Guigard, E., Kay, C. M., & Ryan, R. O. (2008) · Biochemistry · doi:10.1021/bi800515c · Cited by 16
Zhang, K., Zhang, H., Zhang, X., Zheng, X., Quezada, H. C., Zhang, D., & Zhu, J. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.05.050 · Cited by 17
Gerdes, L. U., Lindholt, J. S., Vammen, S., Henneberg, E. W., & Fasting, H. (2000) · British journal of surgery · doi:10.1046/j.1365-2168.2000.01486.x · Cited by 16
Luc, G., Ducimetière, P., Bard, J., Arveiler, D., Evans, A., Cambien, F., Fruchart, J., & Fiévet, C. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(97)00053-1 · Cited by 16
Fumihiko, T., 小林, 祥., Toshio, O., Akihiro, F., & Norihiro, K. (2011) · Genome Research · doi:10.1101/gr.115832.110 · Cited by 15
Phu, T. A., Vu, N. K., Ng, M., Gao, A. S., Stoolman, J. S., Chandel, N. S., & Raffaı̈, R. L. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113206 · Cited by 16
Genetic and environmental risk factors for dementia in African adults: A systematic review
Donkor, D. M., Marfo, E., Bockarie, A. S., Tettevi, E. J., Antwi, M. H., Dogah, J., Osei, G. N., & Simpong, D. L. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70220 · Cited by 15
Belinson, H., & Michaelson, D. M. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1065 · Cited by 15
Gorshkova, I. N., Kypreos, K. E., Gantz, D., Zannis, V. I., & Atkinson, D. (2008) · Biochemistry · doi:10.1021/bi8015857 · Cited by 15
Administration of Downstream ApoE Attenuates the Adverse Effect of Brain ABCA1 Deficiency on Stroke
Wang, X., Li, R., Zacharek, A., Landschoot‐Ward, J., Wang, F., Wu, K.-H., Chopp, M., Chen, J., & Cui, X. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113368 · Cited by 15
Topić, A., Spasojević‐Kalimanovska, V., Zeljković, A., Vekić, J., & Jelić‐Ivanović, Z. (2007) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2007.11.013 · Cited by 15
Is Apolipoprotien E codon 112 Polymorphisms Associated with Recurrent Pregnancy Loss?
Özörnek, H., Ergin, E., Jeyendran, R. S., Özay, A., Pillai, D., & Coulam, C. B. (2010) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2010.00814.x · Cited by 15
Association of Apo E gene polymorphism with HDL level in Tehranian population
DANESHPOUR, M. S., Hedayati, M., Eshraghi, P., & Azizi, F. (2010) · European Journal of Lipid Science and Technology · doi:10.1002/ejlt.200900207 · Cited by 15
Yamamoto, T., Lamoureux, J., & Ryan, R. O. (2006) · Journal of Lipid Research · doi:10.1194/jlr.d600001-jlr200 · Cited by 15
Tagalakis, A. D., Diakonov, I. A., Graham, I. D., Heald, K. A., HARRIS, J., Mulcahy, J. V., Dickson, G., & Owen, J. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2004.10.001 · Cited by 15
Raussens, V., Mah, M. K. H., Kay, C. M., Sykes, B. D., & Ryan, R. O. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005732200 · Cited by 15
Saito, H., Okuhira, K., Tsuchimoto, N., Vertut‐Doï, A., Matsumoto, C., Tanimoto, T., Okada, S., & Handa, T. (2001) · Lipids · doi:10.1007/s11745-001-0664-1 · Cited by 15
Spangenberg, J., & Curtiss, L. K. (1997) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/s0005-2760(97)00123-9 · Cited by 15
Lee, H. (2024) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.4c01132 · Cited by 15
Synergistic reduction in interfacial flexibility of TREM2 R47H and ApoE4 may underlie AD pathology
Lietzke, E. E., Saeb, D., Aldrich, E. C., Bruce, K. D., & Sprenger, K. G. (2025) · Alzheimer s & Dementia · doi:10.1002/alz.70120 · Cited by 16
Apolipoprotein E3 Inhibits Rho to Regulate the Mechanosensitive Expression of Cox2
Hsu, B. Y., Bae, Y., Mui, K. L., Liu, S., & Assoian, R. K. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128974 · Cited by 14
APOE ε 3 Gene Transfer Attenuates Brain Damage after Experimental Stroke
McColl, B. W., McGregor, A. L., Wong, A. P., Harris, J. D., Amalfitano, A., Magnoni, S., Baker, A. H., Dickson, G., & Horsburgh, K. J. (2006) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600361 · Cited by 14
Human apolipoprotein E accelerates microtubule polymerization in vitro
Scott, B. L., Welch, K., deSerrano, V. S., Moss, N. C., Roses, A. D., & Strittmatter, W. J. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00180-3 · Cited by 14
LDL receptor binds newly synthesized apoE in macrophages: a precursor pool for apoE secretion
Zhao, Y., & Mazzone, T. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33506-9 · Cited by 14
APOE Genotype in Relation to Sporadic and Alzheimer-Related CAA
McCarron, M. O., & Nicoll, J. A. R. (2000) · Springer eBooks · doi:10.1007/978-94-017-1007-7_5 · Cited by 14
Mather, M. L., Evangelou, A. V., Bourne, J. N., Macklin, W. B., & Wood, T. L. (2025) · Glia · doi:10.1002/glia.70042 · Cited by 10
Witos, J., Samuelsson, J., Cilpa-Karhu, G., Metso, J., Jauhiainen, M., & Riekkola, M. (2015) · The Analyst · doi:10.1039/c5an00210a · Cited by 13
Damsteegt, E. L., Mizuta, H., Ozaki, Y., Hiramatsu, N., Todo, T., Hara, A., Ijiri, S., Adachi, S., & Lokman, P. M. (2014) · Journal of Comparative Physiology B · doi:10.1007/s00360-014-0821-4 · Cited by 13
LRP-1 Pathway Targeted Inhibition of Vascular Abnormalities in the Retina of Diabetic Mice
Hossain, A., Tauhid, L., Davenport, I. R., Huckaba, T. M., Graves, R. A., Mandal, T. K., Muniruzzaman, S., Ahmed, S. A., & Bhattacharjee, P. S. (2016) · Current Eye Research · doi:10.1080/02713683.2016.1203441 · Cited by 13
Human immunodeficiency virus downregulates podocyteapoEexpression
Arora, S., Husain, M., Kumar, D., Patni, H., Pathak, S., Mehrotra, D., Reddy, V. K., Reddy, L. R., Salhan, D., Yadav, A., et al. (2009) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.90668.2008 · Cited by 13
Tremblay, A. J., Lamarche, B., Ruel, I. L., Hogue, J., Deshaies, Y., Gagné, C., & Couture, P. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.10.037 · Cited by 13
Anionic phospholipids inhibit apolipoprotein E—Low-density lipoprotein receptor interactions
Yamamoto, T., & Ryan, R. O. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.01.066 · Cited by 13
APOE epsilon status in Hungarian patients with primary progressive multiple sclerosis
Losonczi, E., Bencsik, K., Fricska, N., Honti, V., Szalczer, E., Rajda, C., Illés, Z., Mátyás, K., Rózsa, C., Csépány, T., et al. (2010) · Swiss Medical Weekly · doi:10.4414/smw.2010.13119 · Cited by 13
Clayton, D., Brereton, I. M., Kroon, P. A., & Smith, R. (1999) · Protein Science · doi:10.1110/ps.8.9.1797 · Cited by 13
Raffaı̈, R. L., Vukmirica, J., Weisgraber, K. H., Rassart, É., Innerarity, T. L., & Milne, R. W. (1999) · Protein Expression and Purification · doi:10.1006/prep.1999.1031 · Cited by 13
Self-citationCorsetti, J. P., Gansevoort, R. T., Bakker, S. J. L., & Dullaart, R. P. F. (2016) · Journal of clinical lipidology · doi:10.1016/j.jacl.2016.03.003 · Cited by 12
Impact of apoE deficiency during synaptic remodeling in the mouse olfactory bulb
Nwosu, I. C., Gairhe, S., Struble, R. G., & Nathan, B. P. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.05.117 · Cited by 12
Kothari, S., Bala, N., Patel, A., Donovan, A., & Narayanaswami, V. (2021) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2021.183618 · Cited by 11
Moreno, J. A., Pérez‐Jiménez, F., Moreno‐Luna, R., Pérez‐Martínez, P., Fuentes, F. J., Marín, C., Portugal, H., Lairon, D., & López‐Miranda, J. (2008) · British Journal Of Nutrition · doi:10.1017/s0007114508111515 · Cited by 13
Nathan, B. P., Tonsor, M., & Struble, R. G. (2010) · Brain Research · doi:10.1016/j.brainres.2010.04.070 · Cited by 12
Duan, H., Gu, D., & Mazzone, T. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/s1388-1981(00)00005-6 · Cited by 12
ApoE Mimetic Peptides as Therapy for Traumatic Brain Injury
Laskowitz, D. T., & Wyck, D. W. V. (2023) · Neurotherapeutics · doi:10.1007/s13311-023-01413-0 · Cited by 12
Neuropsychiatric symptoms and apolipoprotein E genotypes in neurocognitive disorders
Lozupone, M., Leccisotti, I., Mollica, A., Berardino, G., Moretti, M. C., Altamura, M., Bellomo, A., Daniele, A., Dibello, V., Solfrizzi, V., et al. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-01274 · Cited by 11
Metadata
- Authors
- Weisgraber, K. H.
- Affiliations
- Gladstone Institutes (US)
- Corresponding author
- Weisgraber, Karl H.
- Venue
- Advances in Protein Chemistry
- Publisher
- Elsevier
- Published
- 1994
- Volume
- 45
- Pages
- 249-302
- ISSN
- 0065-3233 (ISSN-L)
- OpenAlex
- W98152484
- Cited by
- 830
- References
- 194
- Citations by year
- 2026: 16 · 2025: 25 · 2024: 14 · 2023: 17 · 2022: 12 · 2021: 20 · 2020: 12 · 2019: 13 · 2018: 14 · 2017: 20 · 2016: 18 · 2015: 15 · 2014: 18 · 2013: 23 · 2012: 26
- FWCI
- 89.45
- Type
- book chapter
- Language
- en
- Open access
- closed
- Locations
- Advances in protein chemistry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (HL-41633, P01HL041633)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Keywords
- apolipoprotein E, lipoprotein metabolism, apolipoprotein structure, APOE isoforms, lipid transfer proteins, lipoprotein receptors, triglyceride-rich lipoproteins, reverse cholesterol transport, lipolysis, serum lipoproteins
- MeSH terms
- Amino Acid Sequence, Animals, Apolipoproteins E, Humans, Molecular Sequence Data, Protein Conformation, Structure-Activity Relationship, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
